Risk of Prostate Cancer in US Veterans With Rheumatoid Arthritis
暂无分享,去创建一个
H. Sayles | Namrata Singh | J. Baker | T. Mikuls | B. Sauer | G. Cannon | P. Roul | Yangyuna Yang | B. England | Austin M Wheeler | Kaitlyn M Brittan
[1] H. Weir,et al. Prostate Cancer Incidence and Survival, by Stage and Race/Ethnicity — United States, 2001–2017 , 2020, MMWR. Morbidity and mortality weekly report.
[2] H. Sayles,et al. Obesity and the Risk of Incident Chronic Opioid Use in Rheumatoid Arthritis , 2020, Arthritis care & research.
[3] G. Lippi,et al. Current Cancer Epidemiology , 2019, Journal of epidemiology and global health.
[4] H. Sayles,et al. Current and early life weight and associations with mortality in rheumatoid arthritis. , 2019, Clinical and experimental rheumatology.
[5] A. D'Amico,et al. Association of Treatment With 5α-Reductase Inhibitors With Time to Diagnosis and Mortality in Prostate Cancer. , 2019, JAMA internal medicine.
[6] M. Terris,et al. Validity of the National Death Index to Ascertain the Date and Cause of Death in Men Having Undergone Prostatectomy for Prostate Cancer , 2019, Prostate Cancer and Prostatic Diseases.
[7] K. Hyrich,et al. Malignancy and rheumatoid arthritis: Epidemiology, risk factors and management. , 2018, Best practice & research. Clinical rheumatology.
[8] M. Thompson,et al. Testosterone treatment and the risk of aggressive prostate cancer in men with low testosterone levels , 2018, PloS one.
[9] H. Sayles,et al. Body Mass Index, Weight Loss, and Cause‐Specific Mortality in Rheumatoid Arthritis , 2018, Arthritis care & research.
[10] M. Benson,et al. A review of Agent Orange and its associated oncologic risk of genitourinary cancers. , 2017, Urologic oncology.
[11] Tyler J. VanderWeele,et al. Sensitivity Analysis in Observational Research: Introducing the E-Value , 2017, Annals of Internal Medicine.
[12] M. Kelley,et al. Cancer Incidence Among Patients of the U.S. Veterans Affairs Health Care System: 2010 Update. , 2017, Military medicine.
[13] Mark S. Litwin,et al. The Diagnosis and Treatment of Prostate Cancer: A Review , 2017, JAMA.
[14] H. Sayles,et al. Associations of Circulating Cytokines and Chemokines With Cancer Mortality in Men With Rheumatoid Arthritis , 2016, Arthritis & rheumatology.
[15] Deborah Cory-Slechta,et al. The National Academies of SCIENCES • ENGINEERING • MEDICINE , 2016 .
[16] M. Hochberg,et al. Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis , 2015, Arthritis Research & Therapy.
[17] H. Sayles,et al. Validation of the Rheumatic Disease Comorbidity Index , 2015, Arthritis care & research.
[18] Michael J. Barry,et al. Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence. , 2014, JAMA.
[19] M. Kelley,et al. Cancer incidence among patients of the U.S. Veterans Affairs Health Care System. , 2012, Military medicine.
[20] J. Singh,et al. Derivation and preliminary validation of an administrative claims-based algorithm for the effectiveness of medications for rheumatoid arthritis , 2011, Arthritis research & therapy.
[21] R. Cress,et al. Risk of cancer among rheumatoid arthritis patients in California , 2009, Cancer Causes & Control.
[22] K. Hemminki,et al. Cancer risk in hospitalized rheumatoid arthritis patients. , 2008, Rheumatology.
[23] Jasvinder A Singh,et al. Accuracy of Veterans Administration databases for a diagnosis of rheumatoid arthritis. , 2004, Arthritis and rheumatism.
[24] P. Heinrich,et al. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. , 2003, The Biochemical journal.
[25] M. Liang,et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.